By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug Administration granted regular approval to tisotumab vedotin-tftv (Tivdak, Seagen Inc. [now a part of Pfizer Inc.]) for
Local Oncologist Involved with the Binaytara Foundation Since 2019 Meet Dr. Fengting Yan, one of our wonderful Education Committee members! Dr. Yan is an oncologist who specializes in women’s cancer practicing at
More
The addition of Dr. Anand Nayak and Mr. Santosh Ray’s Expertise Has Led to an Enhanced Histopathology Laboratory Dr. Anand Kumar Nayak recently joined the BTFCC as a consultant pathologist, and the
More
The conference will be held at the Grand Hyatt in Seattle on April 28-30, 2023 We invite you to attend the 2023 Summit on Cancer Health Disparities (SCHD23) in Seattle, WA! This
More
Watch the video faculty highlight from our Women's Cancer Conference!
More
Read about the Binaytara Foundation October Conferences!
More
Dr. Rubina Suwal of the Binaytara Foundation Cancer Center performs successful oral cancer surgery for patient in local community
More
The Binaytara Foundation hosted two conferences in September 2022
More
Fall brings five conferences to the Pacific Northwest and Utah The Binaytara Foundation has organized five conferences in September and October, located in three states, Washington, Oregon, and Utah. Most of the
More
ASCO Direct™ Highlights Oncology conference held in Seattle to present and discuss the latest findings in cancer research and treatments The Binaytara Foundation held the ASCO Direct™ Highlights: 2022 Official Annual Meeting
More
The Binaytara Foundation (BTF) is pleased to welcome Dr. Sri Tantravahi as the new Co-Chair of the BTF Education Academy. Dr. Tantravahi will work closely with Dr. Sid Yadav, who will also
More